The Expression and Release of Hsp60 in 6-OHDA Induced In Vivo and In Vitro Models of Parkinson’s Disease

[1]  Chun Cheng,et al.  SCYL1BP1 modulates neurite outgrowth and regeneration by regulating the Mdm2/p53 pathway , 2012, Molecular biology of the cell.

[2]  A. Johnson,et al.  TLR4 activates NF-κB in human ovarian granulosa tumor cells. , 2011, Biochemical and biophysical research communications.

[3]  J. Ross,et al.  Heat-shock protein 60 translocates to the surface of apoptotic cells and differentiated megakaryocytes and stimulates phagocytosis , 2011, Cellular and Molecular Life Sciences.

[4]  J. Kasahara,et al.  Role of glial cells in neurotoxin-induced animal models of Parkinson’s disease , 2011, Neurological Sciences.

[5]  J. Rolinger,et al.  Effect of 6-hydroxydopamine (6-OHDA) on proliferation of glial cells in the rat cortex and striatum: evidence for de-differentiation of resident astrocytes , 2010, Cell and Tissue Research.

[6]  Yan-yong Wang,et al.  Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice , 2010, Brain Research.

[7]  Jau-Shyong Hong,et al.  Inhibition of IκB Kinase-β Protects Dopamine Neurons Against Lipopolysaccharide-Induced Neurotoxicity , 2010, Journal of Pharmacology and Experimental Therapeutics.

[8]  Doo Jae Lee,et al.  Cytosolic Hsp60 Is Involved in the NF-κB-Dependent Survival of Cancer Cells via IKK Regulation , 2010, PloS one.

[9]  A. Gupte,et al.  Age-related changes in HSP25 expression in basal ganglia and cortex of F344/BN rats , 2010, Neuroscience Letters.

[10]  Vadim S. Polikov,et al.  Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity. , 2010, Brain : a journal of neurology.

[11]  Chun Cheng,et al.  A relationship between p27(kip1) and Skp2 after adult brain injury: implications for glial proliferation. , 2010, Journal of neurotrauma.

[12]  D. Dexter,et al.  Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6‐hydroxydopamine model of Parkinson’s disease , 2009, Journal of neurochemistry.

[13]  N. Brattig,et al.  Heat shock protein 60 (HSP60) stimulates neutrophil effector functions , 2009, Journal of leukocyte biology.

[14]  H. Kettenmann,et al.  C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation , 2009, Journal of neuroscience research.

[15]  H. Mandel,et al.  Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. , 2008, American journal of human genetics.

[16]  R. Nitsch,et al.  A Vicious Cycle Involving Release of Heat Shock Protein 60 from Injured Cells and Activation of Toll-Like Receptor 4 Mediates Neurodegeneration in the CNS , 2008, The Journal of Neuroscience.

[17]  K. Yoo,et al.  Changes in immunoreactivity of HSP60 and its neuroprotective effects in the gerbil hippocampal CA1 region induced by transient ischemia , 2007, Experimental Neurology.

[18]  M. Block,et al.  Chronic microglial activation and progressive dopaminergic neurotoxicity. , 2007, Biochemical Society transactions.

[19]  S. Simon,et al.  HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. , 2007, American Journal of Physiology. Heart and Circulatory Physiology.

[20]  Honglei Chen,et al.  Peripheral inflammatory biomarkers and risk of Parkinson's disease. , 2007, American journal of epidemiology.

[21]  A. Hofman,et al.  Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease , 2007, Neuroepidemiology.

[22]  Anders Björklund,et al.  Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. , 2007, Brain : a journal of neurology.

[23]  C. Georgopoulos,et al.  A novel mutation in the HSPD1 gene in a patient with hereditary spastic paraplegia , 2007, Journal of Neurology.

[24]  Eric Jacobs,et al.  Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease , 2005, Annals of neurology.

[25]  T. Joh,et al.  Matrix Metalloproteinase-3: A Novel Signaling Proteinase from Apoptotic Neuronal Cells That Activates Microglia , 2005, The Journal of Neuroscience.

[26]  J. Schulz,et al.  Cellular pathology of Parkinson’s disease: astrocytes, microglia and inflammation , 2004, Cell and Tissue Research.

[27]  M. Tsan,et al.  Heat shock protein and innate immunity. , 2004, Cellular & molecular immunology.

[28]  M. Tsan,et al.  Cytokine function of heat shock proteins. , 2004, American journal of physiology. Cell physiology.

[29]  Andre Parent,et al.  Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration , 2003, Annals of neurology.

[30]  Youngbuhm Huh,et al.  Microglial activation and tyrosine hydroxylase immunoreactivity in the substantia nigral region following transient focal ischemia in rats , 2003, Neuroscience Letters.

[31]  S. Gupta,et al.  Cytosolic Heat Shock Protein 60, Hypoxia, and Apoptosis , 2002, Circulation.

[32]  S. Kirchhoff,et al.  Cytosolic Heat Shock Protein 60, Apoptosis, and Myocardial Injury , 2002, Circulation.

[33]  A. Dürr,et al.  Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. , 2002, American journal of human genetics.

[34]  D. Lipsker,et al.  Heat-shock proteins as activators of the innate immune system. , 2002, Trends in immunology.

[35]  H. Karahashi,et al.  Chlamydial Heat Shock Protein 60 Activates Macrophages and Endothelial Cells Through Toll-Like Receptor 4 and MD2 in a MyD88-Dependent Pathway1 , 2002, The Journal of Immunology.

[36]  John Q. Trojanowski,et al.  Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.

[37]  Carsten J. Kirschning,et al.  Endocytosed HSP60s Use Toll-like Receptor 2 (TLR2) and TLR4 to Activate the Toll/Interleukin-1 Receptor Signaling Pathway in Innate Immune Cells* , 2001, The Journal of Biological Chemistry.

[38]  P. Tawa,et al.  Hsp60 accelerates the maturation of pro‐caspase‐3 by upstream activator proteases during apoptosis , 1999, The EMBO journal.

[39]  B. Soltys,et al.  Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (Hsp60) in mammalian cells. , 1996, Experimental cell research.

[40]  H. Itoh,et al.  Mammalian 60-kDa Stress Protein (Chaperonin Homolog). , 1995, The Journal of Biological Chemistry.

[41]  M. Lovett,et al.  Examining the function and regulation of hsp 70 in cells subjected to metabolic stress , 1992, The Journal of cell biology.

[42]  J. Sambrook,et al.  Protein folding in the cell , 1992, Nature.

[43]  S. Gupta,et al.  HSP60, Bax, and cardiac apoptosis , 2007, Cardiovascular Toxicology.

[44]  M. Sawada,et al.  Role of cytokines in inflammatory process in Parkinson's disease. , 2006, Journal of neural transmission. Supplementum.

[45]  J. Trojanowski,et al.  Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. , 2002, Science.

[46]  P. Mcgeer,et al.  Inflammation in Parkinson's disease. , 2001, Advances in neurology.

[47]  B. Soltys,et al.  Mitochondrial proteins at unexpected cellular locations: export of proteins from mitochondria from an evolutionary perspective. , 2000, International review of cytology.